237 related articles for article (PubMed ID: 12589460)
1. [Intravitreal chemotherapy for intraocular lymphoma].
Helbig H; Cerny T; de Smet MD
Ophthalmologe; 2003 Feb; 100(2):145-9. PubMed ID: 12589460
[TBL] [Abstract][Full Text] [Related]
2. Management of non Hodgkin's intraocular lymphoma with intravitreal methotrexate.
de Smet MD
Bull Soc Belge Ophtalmol; 2001; (279):91-5. PubMed ID: 11344720
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience.
Frenkel S; Hendler K; Siegal T; Shalom E; Pe'er J
Br J Ophthalmol; 2008 Mar; 92(3):383-8. PubMed ID: 18303160
[TBL] [Abstract][Full Text] [Related]
4. Treatment of primary intraocular lymphoma (PIOL) has involved systemic, intravitreal or intrathecal chemotherapy and/or radiotherapy.
Itty S; Olson JH; O'Connell DJ; Pulido JS
Retina; 2009 Mar; 29(3):415-6. PubMed ID: 19174721
[No Abstract] [Full Text] [Related]
5. Local methotrexate and dexamethasone phosphate for the treatment of recurrent primary intraocular lymphoma.
Velez G; Boldt HC; Whitcup SM; Nussenblatt RB; Robinson MR
Ophthalmic Surg Lasers; 2002; 33(4):329-33. PubMed ID: 12134997
[TBL] [Abstract][Full Text] [Related]
6. Intraocular methotrexate level after high-dose intravenous infusion.
Henson JW; Yang J; Batchelor T
J Clin Oncol; 1999 Apr; 17(4):1329. PubMed ID: 10561199
[No Abstract] [Full Text] [Related]
7. An Asian patient with intraocular lymphoma treated by intravitreal methotrexate.
Wang JK; Yang CM; Lin CP; Shan YD; Lo AY; Tien HF
Jpn J Ophthalmol; 2006; 50(5):474-478. PubMed ID: 17013703
[TBL] [Abstract][Full Text] [Related]
8. Primary non-Hodgkin's lymphoma of the CNS treated with CHOD/BVAM or BVAM chemotherapy before radiotherapy: long-term survival and prognostic factors.
Bessell EM; Graus F; Lopez-Guillermo A; Lewis SA; Villa S; Verger E; Petit J
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):501-8. PubMed ID: 15145169
[TBL] [Abstract][Full Text] [Related]
9. [Primary intraocular lymphoma invaded to the central nervous system after successful treatment with intraocular methotrexate injection].
Watanabe K; Arai A; Takase H; Takahashi H; Iwanaga Y; Sugamoto Y; Sugita S; Mochizuki M; Miura O
Rinsho Ketsueki; 2009 Mar; 50(3):182-6. PubMed ID: 19352085
[TBL] [Abstract][Full Text] [Related]
10. Intrathecal chemotherapy for recurrent central nervous system intraocular lymphoma.
Mason JO; Fischer DH
Ophthalmology; 2003 Jun; 110(6):1241-4. PubMed ID: 12799254
[TBL] [Abstract][Full Text] [Related]
11. [Concurrent chemo-radiotherapy for localized refractory non-Hodgkin's lymphoma--report of two cases].
Sugimoto T; Matano S; Nishijima H; Kakuta K; Inamura K; Okamura T; Munemoto S; Satoh S
Gan To Kagaku Ryoho; 2007 Jan; 34(1):125-8. PubMed ID: 17220687
[TBL] [Abstract][Full Text] [Related]
12. Long-term survival following radiotherapy and cytarabine chemotherapy for sporadic primary central nervous system lymphoma.
Pöttgen C; Stuschke M; Stüben G; Schmitz A; Schwechheimer K; Wacker HH; Rauhut F; Kleuker S; Wilhelm H; Grehl S; Fehlings T
Strahlenther Onkol; 2003 Sep; 179(9):626-32. PubMed ID: 14628129
[TBL] [Abstract][Full Text] [Related]
13. Treatment outcomes for primary intraocular lymphoma: implications for external beam radiotherapy.
Berenbom A; Davila RM; Lin HS; Harbour JW
Eye (Lond); 2007 Sep; 21(9):1198-201. PubMed ID: 16732210
[TBL] [Abstract][Full Text] [Related]
14. [Primary intraocular lymphoma with unusual clinical presentation and poor outcome].
Pache M; Kain H; Buess M; Flammer J; Meyer P
Klin Monbl Augenheilkd; 2004 May; 221(5):401-3. PubMed ID: 15162291
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and toxicity of intravitreal chemotherapy for primary intraocular lymphoma.
Velez G; Yuan P; Sung C; Tansey G; Reed GF; Chan CC; Nussenblatt RB; Robinson MR
Arch Ophthalmol; 2001 Oct; 119(10):1518-24. PubMed ID: 11594954
[TBL] [Abstract][Full Text] [Related]
16. Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvement.
Smith JR; Rosenbaum JT; Wilson DJ; Doolittle ND; Siegal T; Neuwelt EA; Pe'er J
Ophthalmology; 2002 Sep; 109(9):1709-16. PubMed ID: 12208721
[TBL] [Abstract][Full Text] [Related]
17. [Initial experience of treatment of primary intraocular lymphomas associated with primary CNS lymphomas].
Tropinskaia OF; Grishina EE; Serova NK; Kobiakov GL; Aronov MS; Shishkina LV
Zh Vopr Neirokhir Im N N Burdenko; 2012; 76(4):19-25; discussion 25. PubMed ID: 23033588
[TBL] [Abstract][Full Text] [Related]
18. Intraocular lymphoma.
Goldberg S; Frenkel S; Blumenthal EZ; Solomon A; Pe'er J
Ophthalmology; 2007 Jun; 114(6):1236-7. PubMed ID: 17544793
[No Abstract] [Full Text] [Related]
19. Intraocular T-cell lymphoma due to mycosis fungoides and response to intravitreal methotrexate.
Reddy R; Kim SJ
Ocul Immunol Inflamm; 2011 Aug; 19(4):234-6. PubMed ID: 21770799
[TBL] [Abstract][Full Text] [Related]
20. Clinical review: treatment of vitreoretinal lymphoma.
Pe'er J; Hochberg FH; Foster CS
Ocul Immunol Inflamm; 2009; 17(5):299-306. PubMed ID: 19831557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
